Miracle Mile Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Buy
2,944
+50
+2% +$4.71K ﹤0.01% 937
2026
Q1
$342K Sell
2,894
-837
-22% -$104K ﹤0.01% 688
2025
Q4
$469K Buy
3,731
+299
+9% +$39K 0.01% 586
2025
Q3
$502K Sell
3,432
-361
-10% -$54.6K 0.01% 550
2025
Q2
$592K Buy
3,793
+1,420
+60% +$225K 0.01% 454
2025
Q1
$391K Buy
2,373
+703
+42% +$117K 0.01% 470
2024
Q4
$272K Buy
+1,670
New +$299K 0.01% 541

Other funds holding ZTS

Miracle Mile Advisors's ZTS Position: Q2 2026 in Review

Miracle Mile Advisors increased its Zoetis (ZTS) stake by 1.7% in Q2 2026, buying an estimated $4.71K and bringing the position to 2,944 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #937.

Miracle Mile Advisors first reported a position in ZTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $592K in Q2 2025. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Miracle Mile Advisors held 2,944 shares of Zoetis worth $212K as of Q2 2026.
  • Miracle Mile Advisors bought 50 Zoetis shares in Q2 2026, an estimated $4.71K.
  • Zoetis made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #937 holding.
  • Miracle Mile Advisors first reported a position in Zoetis in Q4 2024 and has held it in 7 quarters since.
  • Miracle Mile Advisors's Zoetis position peaked at $592K in Q2 2025.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.